Shinto Organics (P) Limited
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Olmovin AH 40mg/5mg/12.5mg Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective.
Tablet
Olmovin AH 40mg/5mg/12.5mg Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective. It helps to lower high blood pressure thus reduces chances of future heart attack and stroke.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmovin AH 40mg/5mg/12.5mg Tablet may be taken with or without food but it is better to take it at a fixed time.
No common side effects listed.
It is unsafe to consume alcohol with Olmovin AH 40mg/5mg/12.5mg Tablet.
Olmovin AH 40mg/5mg/12.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Olmovin AH 40mg/5mg/12.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Olmovin AH 40mg/5mg/12.5mg Tablet is a combination of three medicines: Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide. Olmesartan Medoxomil is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels thereby lowering blood pressure. Hydrochlorothiazide is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
You have been prescribed Olmovin AH 40mg/5mg/12.5mg Tablet for the treatment of high blood pressure. Lowering high blood pressure helps prevent strokes and heart attacks. It may cause dizziness. Get up slowly when rising from a sitting or lying position. Olmovin AH 40mg/5mg/12.5mg Tablet may cause dehydration. Drink plenty of fluids and inform your doctor if you develop extreme thirst, muscle weakness or very dry mouth. Use of Olmovin AH 40mg/5mg/12.5mg Tablet during pregnancy or breastfeeding is unsafe.
The use of Olmovin AH 40mg/5mg/12.5mg Tablet can cause dizziness, particularly when rising from a lying or sitting position. To minimize this risk, get up slowly and carefully.
It is strongly advised to avoid taking Olmovin AH 40mg/5mg/12.5mg Tablet during pregnancy as it may cause harm or even death to the fetus. If you become pregnant while using this medication, discontinue its use and consult your doctor immediately.
Making healthy choices can have a positive impact on your overall well-being when using Olmovin AH 40mg/5mg/12.5mg Tablet. Quit smoking, as it increases the risk of heart attack and stroke. If you are overweight or obese, try to lose weight through a balanced diet and regular exercise. Include plenty of fruits and vegetables in your meals to maintain a healthy diet.
Your doctor will periodically check your blood potassium levels to ensure they remain within the normal range. Make sure to attend all scheduled appointments with your healthcare provider.
No, it is crucial to continue using Olmovin AH 40mg/5mg/12.5mg Tablet as advised by your doctor, even if you're feeling well. Stopping the medication abruptly may lead to serious complications such as heart attack and stroke.
Keep the medicine in its original packaging, tightly sealed, and store it according to the instructions provided on the pack or label. Dispose of any unused medication properly, ensuring it is not accessible to pets, children, or other individuals.